EICHOR
● Recruiting
Evaluation for NCI Surgery Branch Clinical Research Protocols
Condition: Synovial Cell Cancer · Melanoma · Colorectal Cancer · Sponsor: National Cancer Institute (NCI)
About this study
Background: The National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient. Objective: This study will allow patients to under screening and evaluation for participation in NC-SB Protocols. Eligibility: Patients 18 years or older must meet the minimum eligibility criteria for an NCI-SB treatment protocol. Design Patients will undergo testing and evaluations as required by the appropriate NCI-SB treatment protocol.
This description comes directly from the study's public registry record.
Talk to the study team
NCI SB Immunotherapy Recruitment Center · (866) 820-4505 · irc@nih.gov
Always discuss trial participation with your own doctor first.
Locations (1)
| National Institutes of Health Clinical Center | Bethesda, Maryland, United States | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00001823